TOKYO, Apr 14 (Pulse News Wire) – Murakami Industries Co., Ltd. (7894.T) announced today that its board of directors held , approved changes in executive positions.
The appointments will take effect pending approval at the upcoming 79th Annual General Meeting scheduled for May 22, 2026. Current President and CEO Shigeru Sugahara will move to a related subsidiary of Koko Pharmaceutical Co., Ltd. His replacement, Takahiro Murakami, currently serving as Executive Director and Head of Corporate Planning Department at Murakami Industries, will assume the role of President and CEO. Murakami was born on July 28, 1,969 and joined Koko Pharmaceutical in April 1,992. He has held various leadership roles within the pharmaceutical division, including regional block manager and department head positions.
Additionally, the company appointed Atsuhito Harano as an external auditor. Harano, who previously served as Manager of PBS Business Group at Mitsubishi Chemical Corporation, will succeed outgoing auditor Daiki Goto. Harano's career includes key roles such as Sustainable Resources Business Unit Manager and Green Transformation Suishin Honbu Development Division Chief at Mitsubishi Chemical. He currently serves as Director of Strategic Management at Mitsubishi Chemical Japan. Both new appointments are set to officially commence on May 22, 2026.
🟡 Confidence: Standard AI-translated content.